INDO-MIM Limited is the largest manufacturer globally of precision engineering components using Metal Injection Molding (MIM) technology, commanding a 6.8% global market share in Calendar Year 2025. The company provides end-to-end, "concept to commissioning" solutions to the manufacturing needs of its customers. The underlying business model integrates mold designing, tooling, and product development across various advanced manufacturing processes, including MIM, investment casting, precision machining, ceramic injection molding, and metal 3D printing (additive manufacturing). The company caters to a highly diversified B2B client base across specialized end-use industries, including the automotive, consumer products, defense, medical, and aerospace sectors. Geographically, INDO-MIM is an export-driven enterprise, generating a significant 77.20% of its revenue from operations outside India in Fiscal 2026. It exports products to 55 countries globally and supports its international footprint with dedicated sales offices in China, Germany, and the United States, along with 13 sales representatives across Europe, Asia, and other regions. The business enjoys strong customer loyalty and minimal switching inclination from its marquee clients. In Fiscal 2026, the company served over 1,100 customers, with repeat customers contributing an exceptional 91.60% of its total revenue from operations. INDO-MIM operates a robust dual-shore manufacturing infrastructure comprising 15 active core manufacturing facilities—six strategically located in India (Karnataka, Andhra Pradesh, and Tamil Nadu), six in the United States, two in the United Kingdom, and one in Mexico. In terms of capacity utilization for Fiscal 2026, the core MIM segment operated with an installed capacity of 874.56 million units at a 30.58% utilization rate. The Precision Machining segment recorded a 54.75% utilization against an installed capacity of 1.41 million units, and the Investment Casting division achieved a 58.55% capacity utilization against an installed capacity of 20.16 million units. On the operational front, the company heavily focuses on efficiency and technological integration, deploying 436 robots and maintaining 476 IoT-enabled machines across its production lines as of March 2026. Its R&D capabilities are focused on developing new materials for MIM and 3D printing technologies, exploring "2K MIM technology" for integrating two different materials in a single mold, and utilizing sacrificial plastic materials to produce intricate geometries without extensive machining. Additionally, recent strategic international acquisitions like Phoenix DeVentures II Inc. and Conway Marsh Garrett Technologies Limited have further strengthened its aerospace, medical device design, and 3D printing capabilities. As per financial performance, INDO-MIM Limited has posted total income / net profits of Rs 2,900.38 Cr / Rs 283.73 Cr (FY24), Rs 3,373.97 Cr / Rs 423.73 Cr (FY25) and Rs 4,320.70 Cr / Rs 533.54 Cr (FY26). So as per previous financials data, the company has shown robust top-line and bottom-line growth driven by higher volume sales and an increasing shift towards high-margin export markets, alongside a successful debt reduction strategy that improved its Debt-to-Equity ratio from 0.53x in FY24 to 0.39x in FY26. Company has an average EPS of Rs 9.44 and average RoNW of 19.61% for the last three fiscals. Based on the pre-issue book value, the issue is priced at a Pre-Issue P/BV of 8.33 as per NAV of Rs 58.24 as on 31.03.26. Factoring in the fresh issue proceeds, the Post-Issue P/BV stands at 7.22. If we attribute the latest earnings of FY24, FY25, and FY26 to the expanded equity base post-issue, then the asking price is at a Post-Issue P/E of around 84.52, 56.60, and 44.95 respectively. As per RHP, there is no listed domestic player. On BRLM's front, HDFC Bank Limited, Axis Capital Limited, ICICI Securities Limited, Kotak Mahindra Capital Company Limited, and SBI Capital Markets Limited are associated with this IPO, and ICICI Securities Limited has handled 49 IPOs in the last three fiscal years. ( As on 20.07.26 ) As per financials, INDO-MIM Limited has shown excellent revenue and profitability growth supported by global market leadership in MIM technology and expanding aerospace and medical device capabilities, RoNW is 21.26% and the Post-Issue P/E is 84.52, 56.60, and 44.95 respectively as per FY24, FY25, and FY26 earnings. So the issue looks fairly priced. The company is a global leader and manufacturer of precision engineering components utilizing metal injection molding offering products starting from metal injection molded parts to investment casting and 3D printed components. So, we give a SUBSCRIBE rating for this IPO. Readers must consult a qualified financial advisor prior to making any actual investment decisions.
✍️ Post a Comment